AMPLITUDE is the first clinical trial to evaluate potential therapies for patients with mHSPC and known HRR gene alterations, with positive results supporting the niraparib-based combination regimen a ...
(Yicai) Jan. 28 -- Chinese medical researchers have made a breakthrough in gene therapy that overcomes the limitations of ...
Delivery of therapeutic genes is essential for gene therapy. Adeno-associated viruses (AAVs) are a prime vector for carrying gene cargoes because of ...
Extracting therapeutic antibodies from biological systems requires stringent purification processes. To reduce costs and accelerate development, novel strategies are essential ...
The Central Drugs Standard Control Organisation (CDSCO) has granted multiple CT-18 approvals between January 2020 and ...
YouTube on MSN
COVID variant recombination: Threat or Achilles heel?
This episode is brought to you by the “Things You Don’t Need to Know” podcast. This show will teach you about things you ...
India's drug regulator, the Central Drugs Standard Control Organisation (CDSCO), has approved a wide range of recombinant DNA (r-DNA)-origin drugs and biologics for manufacture ...
Analyzing genetic data from nearly 140,000 IVF embryos, researchers linked maternal DNA variants to increased risk of ...
Objectives Understanding the molecular changes in the preclinical synovium is crucial for identifying factors that drive ...
Studying over 100,000 embryos revealed genetic factors behind chromosome segregation issues that lead to aneuploidy, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results